A UST Research Team was granted US$20,000 by the Conquer Cancer Foundation of American Society of Clinical Oncology (ASCO) International. The UST Team came up with the iComPASS prototype mobile app that will enable doctors to monitor the symptoms of cancer patients and give medical advice.
The Inter-Disciplinary team of UST was led by by Dr. Teresa Sy Ortin, director of the UST Hospital Benavides Cancer Institute; and Dr. Jocelyn Que, chief program officer of the university’s Center for Pain Medicine, of the UST Faculty of Medicine and Surgery; and the USTH-BCI.
The amount grated will be utilized to help to help finance the group’s project titled “A Mobile Application for Monitoring Patient-Reported Outcomes in Cancer Care.”
For use in mobile phones with iOS and Android Systems, the iComPass (internet-based Computerized Patient Assessment System) was developed in 2014.
The iComPAsS is envisioned to facilitate remote monitoring of patients’ symptoms so the physician can advise the need for a follow-up visit.
It is not intended to formulate a diagnosis, manage symptoms or take the place of a physician, but rather to complement current cancer care by reducing existing barriers that limit adequate management in the local setting – inadequate or delayed detection of symptoms, poor patient compliance, and lack of patient-physician communication.
The project is expected to be completed by next year.
In 2013, the Conquer Cancer Foundation and ASCO International launched the International Innovation Grant, a one-year research grant that provides up to $20,000 in support of novel and innovative projects that can have a significant impact on cancer control in low- and middle-income countries.
UST was one of four recipients of the grant this year.